DAX24.042 -1,1%ESt505.290 -1,0%Top 10 Crypto15,95 +1,7%Dow44.343 ±0,0%Nas20.848 -0,6%Bitcoin101.262 +0,8%Euro1,1756 +0,5%Öl68,27 -1,2%Gold3.429 +1,0%

Werbung

Jetzt Gratis-Aktie sichern! Konto bei XTB eröffnen, Geld einzahlen, Aktie erhalten. Infos: aktien.xtb.com/gratis-aktie. Investments bergen Risiken.

Sarepta Therapeutics Aktie

Kaufen

Verkaufen

Handeln Handeln

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

11,75 EUR ±0,00 EUR ±0,00 %

17:57:26

FSE

14,04 USD +0,75 USD +5,64 %

18:30:11

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Smartphone

Marktkap.1,12 Mrd. EUR

KGV52,00Div. Rendite0,00%

WKNA1J1BH

ISINUS8036071004

SymbolSRPT

Werbung

Sarepta Therapeutics Aktien News

Sortieren:Datum Meistgelesen

16:00PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

21.07.25PR NewswireSRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

21.07.25PR NewswireSRPT Investors Have Opportunity to Join Sarepta Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

WerbungSarepta Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

17.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

14.07.25PR NewswireSRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

12.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

07.07.25PR NewswireSRPT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

07.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

02.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

02.07.25PR NewswireSRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

01.07.25PR NewswireSRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

30.06.25PR NewswireSRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

27.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

22.04.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

15.04.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

31.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

25.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

29.05.24PR NewswireSarepta Therapeutics Set to Join S&P MidCap 400

30.08.23PR NewswireQuest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test

03.04.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

22.03.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

20.03.23PR NewswireINVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SRPT

Sarepta Therapeutics News

Sarepta Therapeutics News: auf dieser Seite finden Sie alle Sarepta Therapeutics News und Nachrichten zur Sarepta Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sarepta Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sarepta Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.